Short answer
Steris (STE) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Richard C. Breeden retiring after 18 years as director at the 2026 annual meeting.
Steris 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Richard C. Breeden retiring after 18 years as director at the 2026 annual meeting
- Departure unrelated to disagreements over Company operations, policies or practices
- Board expanded from nine to ten members with Pierre Boulud’s appointment effective May 5, 2026
- Boulud brings CEO experience at bioMérieux and prior leadership at Ipsen
- Prorated $76,989 director fee payable in career restricted stock units
Item 7.01 · Regulation FD Disclosure
- Exhibit 99.1 accompanies the Form 8-K as the substantive Regulation FD disclosure
- Non-incorporation language limits automatic inclusion in Securities Act registration statements
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Steris 8-K filings
Get the next STE 8-K as it lands
Follow STE for push alerts, or ask the research agent what this filing means.